Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays

Finding new peptide biomarkers for stomach cancer in human sera that can be implemented into a clinically practicable prediction method for monitoring of stomach cancer. We studied the serum peptidome from two different biorepositories. We first employed a C8-reverse phase liquid chromatography appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Meital, Yossef, Rami, Erez, Tamir, Kugel, Aleksandra, Welt, Michael, Karpasas, Mark M., Bones, Jonathan, Rudd, Pauline M., Taieb, Julien, Boissin, Herve, Harats, Dror, Noy, Karin, Tekoah, Yoram, Lichtenstein, Rachel G., Rubin, Eitan, Porgador, Angel
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022591/
https://www.ncbi.nlm.nih.gov/pubmed/21267442
http://dx.doi.org/10.1371/journal.pone.0014540

Ejemplares similares

Ejemplares similares